HighBeam QuickSearch
Get direct access to articles and research when you
add HighBeam to your browser's search toolbar.
|
-
-
Stressgen presents positive HspE7 data that 71% of high grade anal dysplasia patients treated may avoid surgery.
-
PR Newswire; Sep 4, 2001; 700+ Words
Final Complete Data From Both High and Low...4 /PRNewswire/ - Stressgen Biotechnologies Corporation...data continue to support Stressgen's belief that HspE7...Regulatory Affairs of Stressgen. "Many patients now...appeared promising in early research do not demonstrate...
-
-
Stressgen presents longer-term Phase II data on HspE7 for RRP at pediatric conference; -- Interval Between Surgeries Increases with Longer Follow-up; Longer Interval Suggests 70 Fewer Surgeries --.
-
PR Newswire; Nov 3, 2003; 700+ Words
Stressgen Biotechnologies Corporation...presented interim data from its Phase II trial...certain patients respond earlier, and others later...neck cancers. About Stressgen Biotechnologies Corporation: Stressgen, a biopharmaceutical...
-
-
Stressgen announces presentation of data on the mechanism for the immunotherapeutic activity of HspE7 at HPV 2002.
-
PR Newswire; Oct 7, 2002; 700+ Words
...Immune System Stressgen Biotechnologies...SSB) today will present new scientific data at the 20th International...immunity, an early warning system...uniqueness of Stressgen's CoVal(TM...Development at Stressgen. "In fact...
-
-
StressGen Biotechnologies Corp./.
-
PR Newswire; Jul 26, 2000; 376 Words
In VA001, StressGen presents positive clinical data at 18th International Papillomavirus Conference, moved earlier today, we are advised by the company that the text should read ``mcg'' (micrograms) rather than ``mg'' as originally issued
-
-
STRESSGEN MOVING HSPE7 INTO PHASE III AFTER PHASE II ANALYSIS.(Brief Article)
-
BIOWORLD Today; Jun 28, 2000; ; 700+ Words
...Elisabeth Whiting, StressGen's director of...with the program. StressGen does not have the...trial, but will present the data at the International...of the year or early [in the first...data that prompted StressGen to expand HspE7...
-
-
Immunotherapeutic may lessen HPV problems
-
Dermatology Times; Dec 1, 2000; ; 700+ Words
...York - Phase II data confirm the activity...treatment with HspE7 (StressGen Biotechnologies...for antigens which present only in tumor cells...regulatory affairs of StressGen Biotechnologies...system." Once StressGen identified, licensed...proteins are E, or early proteins. One is...
-
-
Economic Hard Times Catch up to Nventa; Cuts Staff 60 Percent.(Nventa Biopharmaceuticals Corp.)
-
BIOWORLD Today; Oct 10, 2008; ; 700+ Words
...McKee attributed the firm's present financial predicament to the...product was safe and provided data to support HspE7's immunologic...which was founded in the early 1990s, has had a history of...which changed its name from Stressgen Biotechnologies Corp. in 2006...
-
-
ICACC Meeting.
-
BIOWORLD Today; Dec 20, 2001; 700+ Words
...candidate Ramoplanin. Data demonstrate the in...Previous Phase II data indicate that Ramoplanin...Calif., released data on its lead compound...Staphylococcus aureus. Stressgen Biotechnologies Corp...levels of the virus present in a patient's...in patients with early treatment ...
-
-
Oleanolic Acid Induces Prostacyclin Release in Human Vascular Smooth Muscle Cells through a Cyclooxygenase-2-Dependent Mechanism1,2
-
The Journal of Nutrition; Mar 1, 2008; ; 700+ Words
...Oleanolic acid induced an early phosphorylation of p38...2 was preceded by an early activation of cAMP regulatory...system than the one earlier attributed to it. Certainly...derived macrophages present in atherosclerotic lesions...in healthy humans and data from both genetically...MEK1/2 ...
|
|